Comparison Between a New PSA Assay With the Well‐Established Beckman Coulter Immunoassay: A Preliminary Report
Analytical Science Advances · 2025-06 · 6 (1)
DOI: 10.1002/ansa.70017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Science Advances, online erschienen am 14.05.2025. Verfasst von Evelina La Civita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medical Sciences University of Naples "Federico II" Naples Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate‐specific antigen (PSA) is a critical biomarker for prostate cancer (PCa) patient clinical management. In this study, we sought to compare three different immunoassays (CLIA): Beckman Coulter Access Hybritech (PSA‐B) (reference method), Immulite 2000 PSA (PSA‐I) and the newly introduced Atellica IM PSA assay (PSA‐A). We selected serum samples from our routine clinical testing at University Hospital Federico II between April and May 2024 from 104 men with a median age of 66 years (interquartile range = 57–74). Total PSA was determined using three different assays: PSA‐B, PSA‐A and PSA‐I. A significant correlation between PSA‐B and PSA‐I assays was found for samples in the overall population (Spearman r ( ρ ) = 0.99, p < 0.0001). PSA‐I displayed a strong correlation with PSA‐B for values below 2 ng/mL ( ρ = 0.98, p < 0.0001), for values between 2 and 10 ng/mL ( ρ = 0.97, p < 0.0001) and for values above 10 ng/mL ( ρ = 0.77, p < 0.0001). A significant positive correlation was found between PSA‐B and PSA‐A in the overall population ( ρ = 0.97, p < 0.0001) and in stratified analyses between PSA‐A and PSA‐B for values below 2 ng/mL ( ρ = 0.86, p < 0.0001), from 2 ng/mL to 10 ng/mL ( ρ = 0.93, p < 0.0001) and above 10 ng/mL ( ρ = 0.77, p < 0.0001). Although both PSA‐I and PSA‐A demonstrated a significant positive correlation with PSA‐B, PSA‐I displayed a significantly better correlation with PSA‐B than PSA‐A in samples with PSA below 2 ng/mL.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Medical Sciences University of Naples "Federico II" Naples Italy.
- Unit of Urology Department of Health Science University of Milan ASST Santi Paolo and Carlo Milan Italy.
ORCID-Profile: Daniela Terracciano
Zitieren
APA
La Civita, E., Fiorenza, M., Jannuzzi, G., Polito, C., Sirica, R., Carbone, G., Sorvillo, D., Saviano, A., Ferro, M., & Terracciano, D. (2025). Comparison Between a New PSA Assay With the Well‐Established Beckman Coulter Immunoassay: A Preliminary Report. Analytical Science Advances, 6(1). https://doi.org/10.1002/ansa.70017
Vancouver
La Civita E, Fiorenza M, Jannuzzi G, Polito C, Sirica R, Carbone G, et al. Comparison Between a New PSA Assay With the Well‐Established Beckman Coulter Immunoassay: A Preliminary Report. Analytical Science Advances. 2025;6(1). doi:10.1002/ansa.70017
BibTeX
@article{LaCivita2025,
author = {La Civita, Evelina and Fiorenza, Mariano and Jannuzzi, Giuseppe and Polito, Carmela and Sirica, Rosa and Carbone, Gianluigi and Sorvillo, Domenica and Saviano, Aniello and Ferro, Matteo and Terracciano, Daniela},
title = {Comparison Between a New PSA Assay With the Well‐Established Beckman Coulter Immunoassay: A Preliminary Report},
journal = {Analytical Science Advances},
year = {2025},
volume = {6},
number = {1},
doi = {10.1002/ansa.70017}
}
EUVIMED